These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 21342735
1. Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agents. Chen J, Liu T, Wu R, Lou J, Dong X, He Q, Yang B, Hu Y. Eur J Med Chem; 2011 Apr; 46(4):1343-7. PubMed ID: 21342735 [Abstract] [Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents. Chen J, Liu T, Wu R, Lou J, Cao J, Dong X, Yang B, He Q, Hu Y. Bioorg Med Chem; 2010 Dec 15; 18(24):8478-84. PubMed ID: 21067933 [Abstract] [Full Text] [Related]
3. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives. Chen J, Dong X, Liu T, Lou J, Jiang C, Huang W, He Q, Yang B, Hu Y. Bioorg Med Chem; 2009 May 01; 17(9):3324-31. PubMed ID: 19359185 [Abstract] [Full Text] [Related]
5. Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety. Nickel HC, Schmidt P, Böhm KJ, Baasner S, Müller K, Gerlach M, Unger E, Günther EG, Prinz H. Eur J Med Chem; 2010 Aug 01; 45(8):3420-38. PubMed ID: 20537765 [Abstract] [Full Text] [Related]
6. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents. Dyrager C, Wickström M, Fridén-Saxin M, Friberg A, Dahlén K, Wallén EA, Gullbo J, Grøtli M, Luthman K. Bioorg Med Chem; 2011 Apr 15; 19(8):2659-65. PubMed ID: 21459004 [Abstract] [Full Text] [Related]
7. Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships. Hu L, Jiang JD, Qu J, Li Y, Jin J, Li ZR, Boykin DW. Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3613-7. PubMed ID: 17482458 [Abstract] [Full Text] [Related]
11. Design, synthesis, and structure-activity relationship studies of novel millepachine derivatives as potent antiproliferative agents. Wang G, Wu W, Peng F, Cao D, Yang Z, Ma L, Qiu N, Ye H, Han X, Chen J, Qiu J, Sang Y, Liang X, Ran Y, Peng A, Wei Y, Chen L. Eur J Med Chem; 2012 Aug 01; 54():793-803. PubMed ID: 22784822 [Abstract] [Full Text] [Related]
12. Design and synthesis of fluoroacylshikonin as an anticancer agent. Kong WY, Chen XF, Shi J, Baloch SK, Qi JL, Zhu HL, Wang XM, Yang YH. Chirality; 2013 Nov 01; 25(11):757-62. PubMed ID: 23908135 [Abstract] [Full Text] [Related]
14. New antitumoral agents I: In vitro anticancer activity and in vivo acute toxicity of synthetic 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one and derivatives. Quincoces Suarez JA, Rando DG, Santos RP, Gonçalves CP, Ferreira E, de Carvalho JE, Kohn L, Maria DA, Faião-Flores F, Michalik D, Marcucci MC, Vogel C. Bioorg Med Chem; 2010 Sep 01; 18(17):6275-81. PubMed ID: 20696583 [Abstract] [Full Text] [Related]
15. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents. Qian Y, Zhang HJ, Lv PC, Zhu HL. Bioorg Med Chem; 2010 Dec 01; 18(23):8218-25. PubMed ID: 21036623 [Abstract] [Full Text] [Related]
16. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL. Eur J Med Chem; 2015 Jun 24; 99():125-37. PubMed ID: 26070164 [Abstract] [Full Text] [Related]